Aequus Pharmaceuticals (AQS) Stock Chart & Stock Price History C$0.0050 0.00 (-37.50%) As of 04/25/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsInsider TradesBuy This Stock Aequus Pharmaceuticals Stock Price Performance The Aequus Pharmaceuticals (AQS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 87.50%, with a year-to-date return of -50.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Aequus Pharmaceuticals traded at C$0.01 with a market cap of C$663 thousand and volume of 100,000 shares. Five years ago, the stock traded at C$0.08, representing a 93.33% decrease over that period. At the time, it had a market cap of C$6.44 million and a volume of 40,400 shares. Receive AQS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance0.00%3 Month Performance-37.50%Year-To-Date Performance-50.00%1 Year Performance-87.50%5 Year Performance-93.33% AQS Stock Chart for Friday, July, 4, 2025 AQS Chart by TradingView Aequus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0007/03/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0007/02/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0007/01/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/30/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/27/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/26/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/25/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/24/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/23/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.00 Get the Latest News and Ratings for AQS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/19/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/18/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/17/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/16/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/13/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/12/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/11/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/10/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/09/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/06/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/05/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/04/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/03/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.00 Related Companies ENTG Stock Chart DHT.UN Stock Chart PWR Stock Chart BHC Stock Chart CRON Stock Chart GUD Stock Chart TLRY Stock Chart Receive AQS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:AQS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aequus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AQS Stock Alerts